Many of health care’s toughest challenges—from delayed diagnoses to inefficient clinical workflows—are waiting for creative solutions. At the Cornell Health AI Hackathon, student teams spent an intense weekend racing to build some of them.
Collaboration Key to Tackling Rare Blood Cancers
April 9, 2026
Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas—blood cancers that arise in immune cells called B cells—yet the same is not true for patients with more rare lymphoma types that originate in immune cells called T cells.
American Cancer Society Grant to Fund Research on Urinary Tract Cancer Therapies
April 7, 2026
A $1 million Research Scholar Grant from the American Cancer Society will help a multi-institution team led by Dr. Bishoy Faltas, associate professor of medicine at Weill Cornell Medicine, to develop new therapy combinations for hard-to-treat urinary tract cancers.
April 2026 EIPM Director's Newsletter
April 2, 2026
Dear Friends & Members of the Englander Institute,
Unusual tumor cells may be overlooked factors in advanced breast cancer
March 12, 2026
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.
The findings highlight the potential importance of these under-studied cells in breast cancer progression.
Study Identifies Gene Linked to Chemotherapy Resistance in Prostate Cancer
March 10, 2026
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. The findings provide important new insights into why patients with metastatic disease often stop responding to a key class of life-prolonging chemotherapy drugs after initially benefiting.
EIPM Researcher Selected for Prostate Cancer Foundation Challenge Award!
March 4, 2026
Dr. Ekta Khurana, an associate professor of systems and computational biomedicine at Weill Cornell Medicine, has received a two-year, $1 million Challenge Award from the Prostate Cancer Foundation to work with researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center on an AI-based method for early detection of treatment-resistant prostate tumor subtypes.
March 2026 EIPM Directors Memo
March 4, 2026
March 2026 EIPM Director's Memo
Dear Friends & Members of the Englander Institute,
EIPM Clinical Director recognized as one of the 2025 Best Female Scientists in the World!
February 9, 2026
Please join us in congratulating our Clinical Director Dr. Cora N.
February 2026 EIPM Director's Memo
February 9, 2026
Dear Friends & Members of the Englander Institute,